p2T-CAG-SpCas9-BlastR Citations (3)

Originally described in: Predictable and precise template-free CRISPR editing of pathogenic variants.
Shen MW, Arbab M, Hsu JY, Worstell D, Culbertson SJ, Krabbe O, Cassa CA, Liu DR, Gifford DK, Sherwood RI Nature. 2018 Nov;563(7733):646-651. doi: 10.1038/s41586-018-0686-x. Epub 2018 Nov 7. PubMed Journal

---

Articles Citing p2T-CAG-SpCas9-BlastR

Articles
Small molecule inhibition of ATM kinase increases CRISPR-Cas9 1-bp insertion frequency. Bermudez-Cabrera HC, Culbertson S, Barkal S, Holmes B, Shen MW, Zhang S, Gifford DK, Sherwood RI. Nat Commun. 2021 Aug 25;12(1):5111. doi: 10.1038/s41467-021-25415-8. PubMed
Considerations and practical implications of performing a phenotypic CRISPR/Cas survival screen. Ashoti A, Limone F, van Kranenburg M, Alemany A, Baak M, Vivie J, Piccioni F, Dijkers PF, Creyghton M, Eggan K, Geijsen N. PLoS One. 2022 Feb 17;17(2):e0263262. doi: 10.1371/journal.pone.0263262. eCollection 2022. PubMed
Human airway submucosal gland organoids to study respiratory inflammation and infection. Lin L, Pou Casellas C, Dost AFM, Begthel H, Korving J, van den Brink S, Dayton T, van Oosterhout MFM, Smakman N, Thomann L, Thiel V, van Es JH, Clevers H. Cell Stem Cell. 2025 Jul 3;32(7):1170-1182.e7. doi: 10.1016/j.stem.2025.05.013. Epub 2025 Jun 12. PubMed

If you have published an article using this material, please email us at to have your article added to this page.